Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Adverum Biotechnologies
ADVM
$64.4M
| $1.41M | ﹤0.01% |
187,765
+54,791
| +41% | +$412K |
|
2177
Leonardo DRS
DRS
$11.2B
| $1.41M | ﹤0.01% |
+70,500
| New | +$1.41M |
|
2178
Porch Group
PRCH
$1.84B
| $1.41M | ﹤0.01% |
458,900
+370,400
| +419% | +$1.14M |
|
|
HEES
2179
DELISTED
H&E Equipment Services
HEES
| $1.41M | ﹤0.01% |
26,900
-45,632
| -63% | -$2.39M |
|
2180
Ampco-Pittsburgh
AP
$51.4M
| $1.4M | ﹤0.01% |
513,208
+38,251
| +8% | +$104K |
|
2181
Franklin Electric
FELE
$4.21B
| $1.4M | ﹤0.01% |
14,497
-43,103
| -75% | -$4.17M |
|
|
CRON
2182
Cronos Group
CRON
$976M
| $1.4M | ﹤0.01% |
+668,700
| New | +$1.4M |
|
2183
Vanguard S&P 500 Value ETF
VOOV
$5.71B
| $1.39M | ﹤0.01% |
8,300
+1,600
| +24% | +$269K |
|
|
ITI
2184
DELISTED
Iteris, Inc.
ITI
| $1.39M | ﹤0.01% |
267,985
+15,200
| +6% | +$79.1K |
|
2185
Caesarstone
CSTE
$48.4M
| $1.39M | ﹤0.01% |
372,378
-26,900
| -7% | -$101K |
|
2186
Simplify Short Term Treasury Futures Strategy ETF
TUA
$643M
| $1.39M | ﹤0.01% |
+60,100
| New | +$1.39M |
|
2187
Civista Bancshares
CIVB
$403M
| $1.39M | ﹤0.01% |
75,265
+1,400
| +2% | +$25.8K |
|
2188
Sphere Entertainment
SPHR
$2.17B
| $1.39M | ﹤0.01% |
+40,835
| New | +$1.39M |
|
2189
Perma-Pipe International
PPIH
$209M
| $1.38M | ﹤0.01% |
173,993
+900
| +0.5% | +$7.14K |
|
2190
Cambium Networks
CMBM
$20.3M
| $1.38M | ﹤0.01% |
230,000
+4,400
| +2% | +$26.4K |
|
2191
1stdibs.com
DIBS
$101M
| $1.38M | ﹤0.01% |
294,636
+21,755
| +8% | +$102K |
|
|
NVTA
2192
DELISTED
Invitae Corporation
NVTA
| $1.38M | ﹤0.01% |
+2,197,698
| New | +$1.38M |
|
2193
Shattuck Labs
STTK
$85.7M
| $1.38M | ﹤0.01% |
193,200
-6,400
| -3% | -$45.6K |
|
2194
M-tron Industries
MPTI
$141M
| $1.38M | ﹤0.01% |
38,554
+3,303
| +9% | +$118K |
|
2195
Upbound Group
UPBD
$1.57B
| $1.38M | ﹤0.01% |
40,512
-6,700
| -14% | -$228K |
|
2196
First Trust Rising Dividend Achievers ETF
RDVY
$16.6B
| $1.37M | ﹤0.01% |
+26,600
| New | +$1.37M |
|
2197
Banco Macro
BMA
$2.71B
| $1.37M | ﹤0.01% |
47,800
-18,500
| -28% | -$531K |
|
2198
Destination XL Group
DXLG
$78.1M
| $1.37M | ﹤0.01% |
311,600
+37,576
| +14% | +$165K |
|
2199
Invesco China Technology ETF
CQQQ
$1.68B
| $1.37M | ﹤0.01% |
38,100
+29,200
| +328% | +$1.05M |
|
2200
UroGen Pharma
URGN
$836M
| $1.37M | ﹤0.01% |
91,300
-69,000
| -43% | -$1.04M |
|